A ruling on the inventiveness of a compound patent for a prostate cancer therapeutic could help create uniform jurisprudence regarding the examination of pharmaceutical patents, says Guan Yue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback